CRNX
Price
$30.51
Change
-$0.01 (-0.03%)
Updated
May 30 closing price
Capitalization
2.86B
68 days until earnings call
MIRM
Price
$44.46
Change
+$0.46 (+1.05%)
Updated
May 30 closing price
Capitalization
2.2B
60 days until earnings call
Interact to see
Advertisement

CRNX vs MIRM

Header iconCRNX vs MIRM Comparison
Open Charts CRNX vs MIRMBanner chart's image
Crinetics Pharmaceuticals
Price$30.51
Change-$0.01 (-0.03%)
Volume$741.5K
Capitalization2.86B
Mirum Pharmaceuticals
Price$44.46
Change+$0.46 (+1.05%)
Volume$336.38K
Capitalization2.2B
CRNX vs MIRM Comparison Chart
Loading...
CRNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MIRM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRNX vs. MIRM commentary
Jun 01, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRNX is a Hold and MIRM is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 01, 2025
Stock price -- (CRNX: $30.51 vs. MIRM: $44.46)
Brand notoriety: CRNX and MIRM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRNX: 73% vs. MIRM: 82%
Market capitalization -- CRNX: $2.86B vs. MIRM: $2.2B
CRNX [@Biotechnology] is valued at $2.86B. MIRM’s [@Biotechnology] market capitalization is $2.2B. The market cap for tickers in the [@Biotechnology] industry ranges from $303.58B to $0. The average market capitalization across the [@Biotechnology] industry is $2.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRNX’s FA Score shows that 0 FA rating(s) are green whileMIRM’s FA Score has 1 green FA rating(s).

  • CRNX’s FA Score: 0 green, 5 red.
  • MIRM’s FA Score: 1 green, 4 red.
According to our system of comparison, MIRM is a better buy in the long-term than CRNX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRNX’s TA Score shows that 3 TA indicator(s) are bullish while MIRM’s TA Score has 5 bullish TA indicator(s).

  • CRNX’s TA Score: 3 bullish, 5 bearish.
  • MIRM’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, MIRM is a better buy in the short-term than CRNX.

Price Growth

CRNX (@Biotechnology) experienced а +2.52% price change this week, while MIRM (@Biotechnology) price change was +1.05% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.39%. For the same industry, the average monthly price growth was +0.48%, and the average quarterly price growth was -5.03%.

Reported Earning Dates

CRNX is expected to report earnings on Aug 08, 2025.

MIRM is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+1.39% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRNX($2.86B) has a higher market cap than MIRM($2.2B). MIRM YTD gains are higher at: 7.521 vs. CRNX (-40.329). MIRM has higher annual earnings (EBITDA): -37.56M vs. CRNX (-373.49M). CRNX has more cash in the bank: 1.27B vs. MIRM (278M). CRNX has less debt than MIRM: CRNX (50.8M) vs MIRM (317M). MIRM has higher revenues than CRNX: MIRM (379M) vs CRNX (760K).
CRNXMIRMCRNX / MIRM
Capitalization2.86B2.2B130%
EBITDA-373.49M-37.56M994%
Gain YTD-40.3297.521-536%
P/E RatioN/AN/A-
Revenue760K379M0%
Total Cash1.27B278M458%
Total Debt50.8M317M16%
FUNDAMENTALS RATINGS
CRNX vs MIRM: Fundamental Ratings
CRNX
MIRM
OUTLOOK RATING
1..100
7181
VALUATION
overvalued / fair valued / undervalued
1..100
91
Overvalued
64
Fair valued
PROFIT vs RISK RATING
1..100
7020
SMR RATING
1..100
5194
PRICE GROWTH RATING
1..100
8646
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MIRM's Valuation (64) in the null industry is in the same range as CRNX (91) in the Pharmaceuticals Major industry. This means that MIRM’s stock grew similarly to CRNX’s over the last 12 months.

MIRM's Profit vs Risk Rating (20) in the null industry is somewhat better than the same rating for CRNX (70) in the Pharmaceuticals Major industry. This means that MIRM’s stock grew somewhat faster than CRNX’s over the last 12 months.

CRNX's SMR Rating (51) in the Pharmaceuticals Major industry is somewhat better than the same rating for MIRM (94) in the null industry. This means that CRNX’s stock grew somewhat faster than MIRM’s over the last 12 months.

MIRM's Price Growth Rating (46) in the null industry is somewhat better than the same rating for CRNX (86) in the Pharmaceuticals Major industry. This means that MIRM’s stock grew somewhat faster than CRNX’s over the last 12 months.

MIRM's P/E Growth Rating (100) in the null industry is in the same range as CRNX (100) in the Pharmaceuticals Major industry. This means that MIRM’s stock grew similarly to CRNX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CRNXMIRM
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
73%
MACD
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
75%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
77%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 2 days ago
75%
Declines
ODDS (%)
Bearish Trend 5 days ago
79%
Bearish Trend 4 days ago
69%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
87%
Aroon
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
75%
View a ticker or compare two or three
Interact to see
Advertisement
CRNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MIRM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GSIYX22.260.09
+0.41%
Goldman Sachs GQG Ptnrs Intl Opps R6
TGWRX13.310.03
+0.23%
Transamerica Large Growth R
OAYWX24.560.01
+0.04%
Oakmark Global Select Advisor
BGEVX13.98-0.01
-0.09%
Baillie Gifford International Growth 5
LDMOX14.18-0.16
-1.12%
Lazard Developing Markets Equity Open

CRNX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRNX has been loosely correlated with XNCR. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if CRNX jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRNX
1D Price
Change %
CRNX100%
-0.03%
XNCR - CRNX
58%
Loosely correlated
+3.43%
IDYA - CRNX
56%
Loosely correlated
-0.80%
DYN - CRNX
56%
Loosely correlated
-2.29%
RVMD - CRNX
55%
Loosely correlated
+0.81%
TRDA - CRNX
55%
Loosely correlated
-3.80%
More

MIRM and

Correlation & Price change

A.I.dvisor indicates that over the last year, MIRM has been loosely correlated with GERN. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if MIRM jumps, then GERN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MIRM
1D Price
Change %
MIRM100%
+1.05%
GERN - MIRM
41%
Loosely correlated
+2.70%
RARE - MIRM
40%
Loosely correlated
-2.85%
CRNX - MIRM
40%
Loosely correlated
-0.03%
FHTX - MIRM
39%
Loosely correlated
-5.56%
KRYS - MIRM
37%
Loosely correlated
+0.28%
More